Cutiss AG
Personalized skin technology to treat skin injuries and defects
We are a Swiss clinical stage life-sciences company providing innovation in regenerative medicine, skin tissue engineering, and beyond.
We aim to provide patients who suffer from large and deep skin defects with the first personalized and automated skin tissue therapy that is safe, effective and accessible for children and adults.
Cutiss AG
Personalized skin technology to treat skin injuries and defects
We are a Swiss clinical stage life-sciences company providing innovation in regenerative medicine, skin tissue engineering, and beyond.
We aim to provide patients who suffer from large and deep skin defects with the first personalized and automated skin tissue therapy that is safe, effective and accessible for children and adults.
Clinical Problem
Skin is our body’s largest organ. Worldwide, millions of people suffer from severe skin defects requiring surgical interventions to restore skin function.
Skin defects can be acute (burns and trauma) or elective (scar revisions, giant nevi or tumor resections, plastic surgery, etc).
Burns are a global public health problem and major cause of death and disability globally. They account for an estimated 180,000 deaths annually. Children represent a large proportion of people with burn injuries globally and often sustain major injuries that require critical and surgical intervention.
Our solution
After more than 20 years of research and development, our lead product denovoSkin™ promises to take skin surgery to the next level and revolutionize current treatments.
denovoSkin™ is a personalized human skin graft that can now be bio-engineered in large quantities, starting from a small, post stamp-sized piece of healthy skin. It promises to grow with the patient, limit scarring, and drastically reduce the number of follow up corrective surgeries required, particularly in children. The outcome is potentially life-saving and life-changing.
Clinical Problem
Skin is our body’s largest organ. Worldwide, millions of people suffer from severe skin defects requiring surgical interventions to restore skin function…
Our solution
We aim to give patients back more of their own skin to make them well again.
After more than 20 years of research and development, our lead product denovoSkin™ promises to take skin surgery to the next level and revolutionize current treatments.
About us
Meet the
CUTISS Team
Our team includes scientists, medical doctors, GMP manufacturers, translational researchers and regulatory experts, clinical trial managers, as well as product and business development and industrial expertise.
News
About us
Meet the
CUTISS Team
Our team includes scientists, medical doctors, GMP manufacturers, translational researchers and regulatory experts, clinical trial managers, as well as product and business development and industrial expertise.
